Amphastar Pharmaceuticals (AMPH) Net Cash Flow Growth (5y) (2018 - 2026)
Powered by 
Analysis
Amphastar Pharmaceuticals (AMPH) Net Cash Flow Growth (5y) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.63 Bn | 38.97 Bn | 2.15 Bn |
| 2 | Viatris | 19.19 Bn | 18.30 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.69 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.48 Bn | 5.35 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.36 Bn | 520.30 Mn | 2.10 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 995.52 Mn | 705.40 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 404.35 Mn | 363.10 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 176.59 Mn | 176.59 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18.31% |
| Mar 31, 2026 | -34.55% |
| Dec 31, 2025 | -65.09% |
| Sep 30, 2025 | 144.13% |
| Jun 30, 2025 | -31.88% |
| Mar 31, 2025 | 29.64% |
| Dec 31, 2024 | -27.37% |
| Sep 30, 2024 | 15.71% |
| Jun 30, 2024 | -17.91% |
| Mar 31, 2024 | 57.98% |
| Dec 31, 2023 | -55.72% |
| Sep 30, 2023 | 42.05% |
| Jun 30, 2023 | -33.05% |
| Mar 31, 2023 | 30.81% |
| Dec 31, 2022 | 0.02% |
| Sep 30, 2022 | 11.25% |
| Jun 30, 2022 | -23.73% |
| Mar 31, 2022 | 57.92% |
| Dec 31, 2021 | 28.58% |
| Sep 30, 2021 | -147.11% |